Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsNA

A Study Looking to Improve Sleep and Reduce Sedentary Behaviour in Those Living With Type 2 Diabetes Mellitus

Sponsor: University of Leicester

NCT ID: NCT06471634

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Access to the study treatment being tested
Type of study
Interventional (receives a drug or procedure)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
CBTi (behavioural), Control - usual care (other), Sedentary behaviour reduction (behavioural)
How long the study runs
Study runs about 22 months (dates as stated)
About the drug or intervention
CBTi — behavioural: A 12 week intervention using CBTi to improve sleep measured using objective and subjective measures. · Control - usual care — other: Participants will be given a leaflet summarising good sleep practice and the advantages of reducing sedentary behaviour. · Sedentary behaviour reduction — behavioural: Participants will be encouraged to increase activity and thus reduce sedentary time.
Patient visit burden
Not specified by the sponsor
Type of study
Testing a treatment
Ages
18 Years to 75 Years
Who
All
Number of participants
44
Started
2024-09-02
Last checked
2025-03

Plain English Summary

What is this study?

  • • Testing a new treatment for diabetes mellitus, type 2
  • • NA - 44 participants
  • • The goal of this clinical feasibility trial is to learn whether the investigators can improve sleep and reduce sedentary behaviour in people living with Type 2 diabetes mellitus with sleep problems

Who can take part?

  • • Ages 18 Years to 75 Years
  • • Diagnosed with diabetes mellitus, type 2

Where?

  • • Leicester - Diabetes Research Centre University Hospitals Leicester

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

The goal of this clinical feasibility trial is to learn whether the investigators can improve sleep and reduce sedentary behaviour in people living with Type 2 diabetes mellitus with sleep problems. The main questions it aims to answer are: • question 1, can objectively measured sleep and sedentary behaviour be improved in the participants and • question 2, what effect will this have on a number of physical and physiological markers. Participants in the intervention group will be asked to keep sleep diaries and attend regular meetings with a qualified coach who will use a specific talking therapy to try to improve sleep and with use behaviour change techniques to help them be less sedentary. Researchers will compare the control group to the intervention group to see if effects differ between groups.

Diabetes Mellitus, Type 2InsomniaSedentary Behavior

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 18 Years - 75 Years
  • Who can join: All genders

What the study is looking for

  • ✓Diagnosed with Diabetes Mellitus type 2 for longer than 3 months
  • ✓Participant is willing and able to give agreement to take part to take part in the study.
  • ✓Sleep disorder symptom checklist 25 (SDS-CL-25) of ≥5 on insomnia criteria.
  • ✓Glycated haemoglobin (HbA1c) of 10% or less (86 mmol/mol) or less
  • ✓Male or Females.

Who cannot take part

  • ✗Individuals living with narcolepsy or diagnosed parasomnia
  • ✗Individuals with type 1 diabetes or gestational diabetes
  • ✗Recent cardiovascular event (within the last 6 months).
  • ✗Currently on opioids
  • ✗Diagnosed with borderline personality disorder, psychosis, adult attention deficit hyperactivity disorder (ADHD) or...
See the full criteria
Inclusion Criteria: * Diagnosed with Diabetes Mellitus type 2 for longer than 3 months * Participant is willing and able to give informed consent to take part in the study. * Sleep disorder symptom checklist 25 (SDS-CL-25) of ≥5 on insomnia criteria. * Not at high risk of undiagnosed Obstructive Sleep Apnoea (OSA), scoring ≥5 on STOP BANG scale (snoring, tired, observed, pressure, body mass index, age, neck size, gender) diagnosed treated OSA is acceptable. * Glycated haemoglobin (HbA1c) of 10% or less (86 mmol/mol) or less * Male or Females. * ≥ 18 ≤ 75 years of age. * Able to walk without the use of an assistive device or requiring assistance from another person. * Not undertaking more than 75 minutes a week of strenuous exercise or sport. * Not taking opioids * Be treatment stable for at least 3 months * Accelerometer measurement of SE ≤ 85% * An understanding that CBTi may exacerbate sleep deprivation in the short term which may impact on certain aspects of daily life. Exclusion Criteria: * Individuals living with narcolepsy or diagnosed parasomnia * Individuals with type 1 diabetes or gestational diabetes * Recent cardiovascular event (within the last 6 months). * Currently on opioids * Diagnosed with borderline personality disorder, psychosis, adult attention deficit hyperactivity disorder (ADHD) or schizophrenia (self-reported). * Individuals living with epilepsy or seizures. * Shift workers * Female participant planning to become pregnant with the timeframe of the study or is currently pregnant. * Terminal illness.

Where Is This Study? (1 UK site)

Diabetes Research Centre University Hospitals Leicester

Leicester LE5 4PW, United Kingdom

Recruiting
Site contact (verified)
Alix HA Covenant, MScahac1@leicester.ac.uk

How to Get in Touch

Alix HA Covenant, MSc

Sponsor contact

CONTACT

01162588572 ahac1@leicester.ac.uk

Joe Henson, PhD

Sponsor contact

CONTACT

1162588572 jjh18@leicester.ac.uk
Data sourced from ClinicalTrials.gov · Last verified: 2025-03